We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Immune Profiling of Tumors May Better Stage Early Cancers.
- Authors
Gunjan Sinha
- Abstract
The article focuses on the move of the Society for Immunotherapy of Cancer (SITC) to validate Immunoscore, which is an assay aimed at quantifying immune response. Topics discussed include the statement of doctor Jerome Galon on the role of an immune profile in predicting cancer survival, the use of chemotherapy, and the potential of Immunoscore in other cancers such as breast and rectal cancer.
- Subjects
IMMUNOTHERAPY; IMMUNE response; GALON, Jerome; CANCER treatment; CANCER chemotherapy; BREAST cancer treatment; RECTAL cancer treatment
- Publication
JNCI: Journal of the National Cancer Institute, 2015, Vol 107, Issue 6, p1
- ISSN
0027-8874
- Publication type
Article
- DOI
10.1093/jnci/djv164